COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,708 Articles (22,913 medRxiv, 8,795 bioRxiv)

Most recent first Previous |  Page 2789: Articles 27881-27890  | Next

A replication-competent vesicular stomatitis virus for studies of SARS-CoV-2 spike-mediated cell entry and its inhibition
Dieterle, M. E., Haslwanter, D., Bortz, R. H., Wirchnianski, A. S., Lasso, G., Vergnolle, O., Abbasi, S. A., Fels, J. M., Laudermilch, E., Florez, C., Mengotto, A., Kimmel, D., Malonis, R. J., Georgiev, G., Quiroz, J., Barnhill, J., Pirofski, L.-A., Daily, J. P., Dye, J. M., Lai, J. R., Herbert, A. S., Chandran, K., Jangra, R. K.
10.1101/2020.05.20.105247 — Posted: 2020-05-20
Clinical And Analytical Performance Of An Automated Serological Test That Identifies S1/S2 Neutralizing IgG In Covid-19 Patients Semiquantitatively.
Bonelli, F., Sarasini, A., Zierold, C., Calleri, M., Bonetti, A., Vismara, C. S., Blocki, F. A., Pallavicini, L., Chinali, A., Campisi, D., Percivalle, E., DiNapoli, A. P., Perno, C. F., Balldanti, F.
10.1101/2020.05.19.105445 — Posted: 2020-05-20 Discussion: Onsite
CD8+ T cell cross-reactivity against SARS-CoV-2 conferred by other coronavirus strains and influenza virus
Koohy, H., Hyun-Jung Lee, C., Pereira Pinho, M., Buckley, P., Woodhouse, I. B., Ogg, G., Simmons, A., Napolitani, G.
10.1101/2020.05.20.107292 — Posted: 2020-05-20
RdRp mutations are associated with SARS-CoV-2 genome evolution
Eskier, D., Karakülah, G., Suner, A., Oktay, Y.
10.1101/2020.05.20.104885 — Posted: 2020-05-20
SARS-CoV-2 targets cortical neurons of 3D human brain organoids and shows neurodegeneration-like effects
Gopalakrishnan, J., Ramani, A., Mueller, L., Niklas Ostermann, P., Gabriel, E., Islam Pranty, A., Mueller-Shiffmann, A., Mariappan, A., Goureau, O., Gruell, H., Walker, A., Andree, M., Hauka, S., Wohlgemuth, K., Omran, H., Klein, F., Wieczorek, D., Adams, O., Timm, J., Korth, C., Schaal, H., Houwaart, T., Dilthey, A.
10.1101/2020.05.20.106575 — Posted: 2020-05-20 Discussion: Onsite | Offsite
A Multiple Peptides Vaccine against nCOVID-19 Designed from the Nucleocapsid phosphoprotein (N) and Spike Glycoprotein (S) via the Immunoinformatics Approach
Abd Albagi, S. O., Al-Nour, M. Y., Elhag, M., Abdelihalim, A. T. I., Haroun, E. M., Essa, M. E. A., Abubaker, M., Hassan, M. A.
10.1101/2020.05.20.106351 — Posted: 2020-05-20
Type I and Type III IFN Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures
Vanderheiden, A., Ralfs, P., Chirkova, T., Upadhyay, A. A., Zimmerman, M. G., Bedoya, S., Aoued, H., Tharp, G. K., Pellegrini, K., Lowen, A. C., Menachery, V. D., Anderson, L. J., Grakoui, A., Bosinger, S. E., Suthar, M. S.
10.1101/2020.05.19.105437 — Posted: 2020-05-20 Discussion: Onsite | Offsite
Discovery of potent inhibitors of PLproCoV2 by screening libraries of selen-containing compounds
Weglarz-Tomczak, E., Tomczak, J. M., Giurg, M., Burda-Grabowska, M.
10.1101/2020.05.20.107052 — Posted: 2020-05-20
Prediction of the virus incubation period for COVID-19 and future outbreaks
Gussow, A. B., Auslander, N., Wolf, Y. I., Koonin, E. V.
10.1101/2020.05.19.104513 — Posted: 2020-05-20
Tiger team: a panel of human neutralizing mAbs targeting SARS-CoV-2 spike at multiple epitopes
Noy-Porat, T., Makdasi, E., Alcalay, R., Mechaly, A., Levy, Y., Bercovich-Kinori, A., Zauberman, A., Tamir, H., Yahalom-Ronen, Y., Israeli, M., Epstein, E., Achdout, H., Melamed, S., Chitlaru, T., Weiss, S., Peretz, E., Rosen, O., Paran, N., Yitzhaki, S., Shapira, S. C., Israely, T., Mazor, O., Rosenfeld, R.
10.1101/2020.05.20.106609 — Posted: 2020-05-20

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).